New supplement aims to tame blood sugar in prediabetes
NCT ID NCT07263789
First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study is testing whether a supplement called Euglycem, taken alongside a standard diet, can lower fasting blood sugar in people with dysglycemia (abnormal blood sugar levels). About 108 participants will be randomly assigned to receive either Euglycem plus diet advice or diet advice alone for three months. The goal is to see if the supplement helps control blood sugar better than diet alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
NOT_YET_RECRUITINGPavia, Pavia, 27100, Italy
Contact Email: •••••@•••••
-
IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.